Literature DB >> 24971537

DEPDC1B enhances migration and invasion of non-small cell lung cancer cells via activating Wnt/β-catenin signaling.

Yi Yang1, Lei Liu2, Junchao Cai2, Jueheng Wu2, Hongyu Guan3, Xun Zhu2, Jie Yuan4, Mengfeng Li5.   

Abstract

Non-small cell lung cancer (NSCLC) remains a highly challenging and deadly malignancy with limited improvements in prognosis over years. Further understanding the molecular events involved in NSCLC oncogenesis and progression will help develop new and effective therapeutic strategies. In this study, we identified a ubiquitous up-regulation of DEPDC1B in NSCLC cell lines and clinical specimens, as well as its inverse correlation with patient survival. Ectopic expression of DEPDC1B endowed NSCLC cells with enhanced migration and invasion, while silencing its expression suppressed these traits. Mechanistic study showed that DEPDC1B was able to activate Wnt/β-catenin signaling, and that depletion of TCF4 or LEF1 abrogated the biological effects of DEPDC1B on cellular migration and invasion. Taken together, our data demonstrate that DEPDC1B might confer metastasis-related malignant phenotype to NSCLC in a Wnt/β-catenin dependent manner, providing new insights in developing novel anti-NSCLC strategies.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DEPDC1B; Invasion; Migration; Non-small cell lung cancer; Wnt/β-catenin

Mesh:

Substances:

Year:  2014        PMID: 24971537     DOI: 10.1016/j.bbrc.2014.06.076

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

1.  The two faces of TOE-2.

Authors:  Mark Gurling; Gian Garriga
Journal:  Worm       Date:  2015-02-03

2.  High levels of DEPDC1B predict shorter biochemical recurrence-free survival of patients with prostate cancer.

Authors:  Shoumin Bai; Ting Chen; Tao Du; Xianju Chen; Yiming Lai; Xiaoming Ma; Wanhua Wu; Chunhao Lin; Leyuan Liu; Hai Huang
Journal:  Oncol Lett       Date:  2017-09-22       Impact factor: 2.967

3.  TGIF1 promoted the growth and migration of cancer cells in nonsmall cell lung cancer.

Authors:  Guo Xiang; Yang Yi; He Weiwei; Wu Weiming
Journal:  Tumour Biol       Date:  2015-06-24

4.  Stimulation of the hypoxia pathway modulates chemotherapy resistance in Hodgkin's lymphoma cells.

Authors:  Stefanie Kewitz; Lars Kurch; Ines Volkmer; Martin S Staege
Journal:  Tumour Biol       Date:  2015-12-30

5.  Upregulation of circ_001569 predicts poor prognosis and promotes cell proliferation in non-small cell lung cancer by regulating the Wnt/β-catenin pathway.

Authors:  Lingchi Ding; Weidong Yao; Junguo Lu; Jun Gong; Xiaodong Zhang
Journal:  Oncol Lett       Date:  2018-05-08       Impact factor: 2.967

6.  Identification of the GTPase-activating protein DEP domain containing 1B (DEPDC1B) as a transcriptional target of Pitx2.

Authors:  Di Wu; Xiaoxi Zhu; Kevin Jimenez-Cowell; Alexander J Mold; Christopher C Sollecito; Nicholas Lombana; Meng Jiao; Qize Wei
Journal:  Exp Cell Res       Date:  2015-02-19       Impact factor: 3.905

Review 7.  Fixing the GAP: The role of RhoGAPs in cancer.

Authors:  Gabriel Kreider-Letterman; Nicole M Carr; Rafael Garcia-Mata
Journal:  Eur J Cell Biol       Date:  2022-02-10       Impact factor: 6.020

8.  Benzyl isothiocyanate inhibits breast cancer cell tumorigenesis via repression of the FoxH1-Mediated Wnt/β-catenin pathway.

Authors:  Yantao Liu; Lingli Zhang; Yao Meng; Liang Huang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

9.  SOSTDC1 is down-regulated in non-small cell lung cancer and contributes to cancer cell proliferation.

Authors:  Lei Liu; Shanshan Wu; Yi Yang; Junchao Cai; Xun Zhu; Jueheng Wu; Mengfeng Li; Hongyu Guan
Journal:  Cell Biosci       Date:  2016-04-14       Impact factor: 7.133

10.  Artemisia argyi Essential Oil Inhibits Hepatocellular Carcinoma Metastasis via Suppression of DEPDC1 Dependent Wnt/β-Catenin Signaling Pathway.

Authors:  Yanli Li; Yang Tian; Wei Zhong; Ning Wang; Yafeng Wang; Yan Zhang; Zhuangli Zhang; Jianbo Li; Fang Ma; Zhihong Zhao; Youmei Peng
Journal:  Front Cell Dev Biol       Date:  2021-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.